Panel calls for a new look at treatments commonly used for chroni...( Many of the medications widely used to ...),Health

Many of the medications widely used to manage chronic insomnia have not yet been rigorously evaluated for long-term use, according to an independent scientific panel convened this week by the National Institutes of Health. This is a critical consideration because for many patients, insomnia can persist for decades. The panel also stressed that many chronic insomnia sufferers could benefit from currently underused behavioral and cognitive therapies.

The panel was concerned that many of the drugs now used to treat insomnia, such as antidepressants and antihistamines, have not been approved for this indication; their efficacy in treating chronic insomnia has not been proven. Even those medications that have been approved for insomnia are approved only for short-term use, leaving chronic sufferers with few proven options. The panel noted that newer benzodiazepine receptor agonist medications have been developed that have fewer and less severe adverse effects than other medications, and show promise for long-term use, but this requires further evaluation. The panel also expressed concern that many insomnia sufferers self-medicate with alcohol, despite the numerous risks involved and the clear evidence that alcohol actually has a negative overall effect on the quality of sleep.

Research indicates that behavioral methods such as relaxation training can be effective to treat insomnia when combined with cognitive therapies specifically targeted at anxiety-producing beliefs and erroneous beliefs about sleep and sleep loss. Moreover, this approach is unlikely to carry adverse side effects, and its benefits may be longer lasting than pharmacological interventions. There are few practitioners trained in these therapies, however.

Alan Leshner, Ph.D., Chief Executive Officer of the American Association for the Advancement of Science and chair of the conference panel explained, "we know that patients can struggle for years with insomnia, and we know that th
'"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/Office of the Director
15-Jun-2005

Page: 1 2 3
Related medicine news :

1. Panel offers guidelines on skin reactions to new class of cancer drugs
2. Panel offers expert analysis on causes, prevention of stent thrombosis
3. Panel presents Agricultural Biosecurity & Sustainability Strategies at 2007 AAAS Meeting
4. Panel updates guidelines for treatment of adult HIV infection
5. Panel finds insufficient evidence to recommend for or against maternal-request Caesarean delivery
6. Report calls for new directions, innovative approaches in testing chemicals for toxicity to humans
7. National Academy of Sciences Institute of Medicine report calls for more dairy foods at school
8. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
9. Civil society movement calls for transparency in the WHO director-general elections
10. Proposal calls for sweeping changes at US Food and Drug Administration
11. Study calls for 39 percent more family physicians